Allgens Medical Technology Co. Ltd. A
Allgens Medical Technology CO., LTD. engages in the research and development, production, and sale of biomedical materials and related medical device products in China. The company offers collagen artificial bone repair materials to agents and terminal hospitals. Its products include Tooth Shell for the treatment of oral or plastic surgery and BonGold for the treatment of orthopedic bone defect r… Read more
Allgens Medical Technology Co. Ltd. A - Asset Resilience Ratio
Allgens Medical Technology Co. Ltd. A (688613) has an Asset Resilience Ratio of 58.93% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Allgens Medical Technology Co. Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Allgens Medical Technology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥910.44 Million | 58.93% |
| Total Liquid Assets | CN¥910.44 Million | 58.93% |
Asset Resilience Insights
- Very High Liquidity: Allgens Medical Technology Co. Ltd. A maintains exceptional liquid asset reserves at 58.93% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Allgens Medical Technology Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Allgens Medical Technology Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Allgens Medical Technology Co. Ltd. A (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Allgens Medical Technology Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 58.19% | CN¥895.57 Million | CN¥1.54 Billion | -0.92pp |
| 2023-12-31 | 59.11% | CN¥902.18 Million | CN¥1.53 Billion | +3.18pp |
| 2022-12-31 | 55.93% | CN¥816.08 Million | CN¥1.46 Billion | +10.07pp |
| 2021-12-31 | 45.85% | CN¥653.88 Million | CN¥1.43 Billion | -12.62pp |
| 2020-12-31 | 58.48% | CN¥470.70 Million | CN¥804.93 Million | +5.51pp |
| 2019-12-31 | 52.97% | CN¥379.30 Million | CN¥716.08 Million | -- |